BDBM79457 2-[[1-(2-morpholin-4-ylethyl)-2-oxidanylidene-5,6,7,8-tetrahydroquinazolin-4-yl]sulfanyl]-N-(3-nitrophenyl)ethanamide::2-[[1-(2-morpholin-4-ylethyl)-2-oxo-5,6,7,8-tetrahydroquinazolin-4-yl]sulfanyl]-N-(3-nitrophenyl)acetamide::2-[[1-[2-(4-morpholinyl)ethyl]-2-oxo-5,6,7,8-tetrahydroquinazolin-4-yl]thio]-N-(3-nitrophenyl)acetamide::2-[[2-keto-1-(2-morpholinoethyl)-5,6,7,8-tetrahydroquinazolin-4-yl]thio]-N-(3-nitrophenyl)acetamide::SR-01000843086::SR-01000843086-1::cid_18578712

SMILES CCCN1CCC2CC1c1cc(-c3cccc(C(F)(F)F)c3)ccc12

InChI Key InChIKey=UDBILFOPWASRIZ-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 79457   

TargetSigma intracellular receptor 2(Human)
University of Texas System

US Patent
LigandChemical structure of BindingDB Monomer ID 79457BDBM79457(US20250387403, Example Table1.34)
Affinity DataKi:  112nMAssay Description:Keywords: apoptosis, BH3 domain, Bcl2-A1, BIM, caspase, cancer Primary Collaborator: Todd Golub, Broad Institute, golub@broadinstitute.org Assay Over...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/6/2026
Entry Details
US Patent